Steven Cohen's TECH Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 294,958 shares of Bio-Techne Corporation (TECH) worth $15.41 M, representing 0.02% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TECH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 1.12 M shares. Largest reduction occurred in Q4 2024, reducing 1.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +294,958 | New Buy | 294,958 | $52.26 |
| Q3 2025 | -787,624 | Sold Out | 0 | $0.00 |
| Q2 2025 | +289,969 | Add 58.27% | 787,624 | $51.45 |
| Q1 2025 | +497,655 | New Buy | 497,655 | $58.63 |
| Q4 2024 | -1.12 M | Sold Out | 0 | $0.00 |
| Q3 2024 | +1.12 M | New Buy | 1.12 M | $79.93 |
| Q3 2023 | -788,697 | Sold Out | 0 | $0.00 |
| Q2 2023 | -178,288 | Reduce 18.44% | 788,697 | $81.63 |
| Q1 2023 | +840,385 | Add 663.81% | 966,985 | $74.19 |
| Q4 2022 | +126,600 | New Buy | 126,600 | $82.88 |
| Q2 2022 | -15,572 | Sold Out | 0 | $0.00 |
| Q1 2022 | +15,572 | New Buy | 15,572 | $108.27 |
| Q4 2021 | -93,572 | Sold Out | 0 | $0.00 |
| Q3 2021 | -39,532 | Reduce 29.70% | 93,572 | $121.15 |
| Q2 2021 | -255,088 | Reduce 65.71% | 133,104 | $112.57 |
| Q1 2021 | +388,192 | New Buy | 388,192 | $95.48 |
| Q3 2020 | -22,012 | Sold Out | 0 | $0.00 |
| Q2 2020 | -571,588 | Reduce 96.29% | 22,012 | $66.01 |
| Q1 2020 | +582,000 | Add 5017.24% | 593,600 | $47.41 |
| Q4 2019 | +9,600 | Add 480.00% | 11,600 | $54.91 |
| Q3 2019 | -400 | Reduce 16.67% | 2,000 | $49.00 |
| Q2 2019 | +2,400 | New Buy | 2,400 | $52.08 |
Steven Cohen's Bio-Techne Corporation Investment FAQs
Steven Cohen first purchased Bio-Techne Corporation (TECH) in Q2 2019, acquiring 2,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Bio-Techne Corporation (TECH) for 22 quarters since Q2 2019.
Steven Cohen's largest addition to Bio-Techne Corporation (TECH) was in Q3 2024, adding 1,122,527 shares worth $89.72 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 294,958 shares of Bio-Techne Corporation (TECH), valued at approximately $15.41 M.
As of the Q1 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Bio-Techne Corporation (TECH) was 1,122,527 shares, as reported at the end of Q3 2024.